Yaping Joyce Liao Selected Research

Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy)

12/2022	Upregulation of retinal VEGF and connexin 43 in murine nonarteritic anterior ischemic optic neuropathy induced with 577 nm laser.
1/2021	Immunoprofiling of Nonarteritic Anterior Ischemic Optic Neuropathy.
1/2021	Dual Specific Phosphatase 14 Deletion Rescues Retinal Ganglion Cells and Optic Nerve Axons after Experimental Anterior Ischemic Optic Neuropathy.
1/2019	Increased ER Stress After Experimental Ischemic Optic Neuropathy and Improved RGC and Oligodendrocyte Survival After Treatment With Chemical Chaperon.
12/2018	A Small Molecule TrkB Neurotrophin Receptor Partial Agonist as Possible Treatment for Experimental Nonarteritic Anterior Ischemic Optic Neuropathy.
1/2017	Experimental Anterior Ischemic Optic Neuropathy in Diabetic Mice Exhibited Severe Retinal Swelling Associated With VEGF Elevation.
5/2015	Optical coherence tomography study of retinal changes in normal aging and after ischemia.
9/2014	Severe, early axonal degeneration following experimental anterior ischemic optic neuropathy.
9/2013	Optical coherence tomography study of experimental anterior ischemic optic neuropathy and histologic confirmation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yaping Joyce Liao Research Topics

Disease

9	Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy) 12/2022 - 09/2013
6	Ischemia 12/2022 - 09/2013
6	Ganglion Cysts (Ganglion) 01/2021 - 09/2013
5	Thrombosis (Thrombus) 12/2022 - 09/2013
3	Inflammation (Inflammations) 01/2021 - 01/2017
3	Optic Nerve Diseases (Optic Neuropathy) 01/2019 - 09/2014
2	Papilledema 12/2022 - 01/2021
2	Hypoxia (Hypoxemia) 01/2021 - 01/2020
2	Diplopia (Double Vision) 06/2018 - 09/2017
1	Central Nervous System Diseases (CNS Diseases) 12/2022
1	Cogan type oculomotor Apraxia 09/2021
1	Parkinsonian Disorders (Parkinsonism) 09/2021
1	Optic Disk Drusen (Optic Disc Drusen) 01/2021
1	Edema (Dropsy) 01/2021
1	Gliosis 01/2021
1	Vision Disorders (Hemeralopia) 01/2021
1	Giant Cell Arteritis (Horton Disease) 01/2019
1	Optic Nerve Injuries 01/2019
1	Ocular Motility Disorders (Convergence Insufficiency) 09/2017
1	Trochlear Nerve Diseases (Fourth Nerve Palsy) 09/2017
1	Vasculitis (Vasculitides) 01/2017
1	Hyperplasia 01/2017
1	Hyperglycemia 01/2017
1	Retinal Degeneration 09/2014
1	Arteriovenous Malformations (Arteriovenous Malformation) 03/2012
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2011
1	Cerebellar Ataxia (Dysmetria) 02/2008
1	Intracranial Hypotension 07/2007

Drug/Important Bio-Agent (IBA)

14	Retinaldehyde (Retinal)IBA 12/2022 - 03/2012
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2022 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2021
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2018
2	CytokinesIBA 01/2021 - 01/2017
2	MitogensIBA 01/2021 - 12/2018
1	ConnexinsIBA 12/2022
1	Rose BengalIBA 12/2022
1	Biological ProductsIBA 12/2022
1	Connexin 43 (Connexin43)IBA 12/2022
1	Glial Fibrillary Acidic ProteinIBA 12/2022
1	Messenger RNA (mRNA)IBA 12/2022
1	Dihydroxyphenylalanine (Dopa)IBA 09/2021
1	ChemokinesIBA 01/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	Chemokine CCL26IBA 01/2021
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2021
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2021
1	4-phenylbutyric acid (Buphenyl)FDA Link 01/2019
1	Antiviral Agents (Antivirals)IBA 01/2019
1	Endoplasmic Reticulum Chaperone BiPIBA 01/2019
1	tropomyosin kinaseIBA 12/2018
1	N,N',N'- tris(2- hydroxyethyl)- 1,3,5- benzenetricarboxamideIBA 12/2018
1	Pharmaceutical PreparationsIBA 12/2018
1	Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA 12/2018
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 12/2018
1	trkB ReceptorIBA 12/2018
1	Acetazolamide (Diamox)FDA LinkGeneric 06/2018
1	Insulin (Novolin)FDA Link 01/2017
1	interleukin-21 (interleukin 21)IBA 01/2017
1	Interleukin-17 (Interleukin 17)IBA 01/2017
1	CalciumIBA 01/2017
1	Streptozocin (Streptozotocin)FDA Link 01/2017
1	Phenobarbital (Luminal)FDA Link 01/2017
1	Annexin A5IBA 09/2014
1	Carisoprodol (Soma)FDA LinkGeneric 09/2014
1	Fluorescein (Funduscein)FDA LinkGeneric 03/2012
1	Cytarabine (Cytosar-U)FDA LinkGeneric 03/2011
1	Peptides (Polypeptides)IBA 02/2008
1	Membrane Proteins (Integral Membrane Proteins)IBA 02/2008

Therapy/Procedure

2	Lasers (Laser) 12/2022 - 09/2013
2	Therapeutics 01/2019 - 12/2018
1	Aftercare (After-Treatment) 01/2019
1	Telescopes 09/2017
1	Glycemic Control 01/2017
1	Drug Therapy (Chemotherapy) 03/2011
1	Catheters 07/2007